» Articles » PMID: 35213095

The Use of Transabdominal Ultrasound in Inflammatory Bowel Disease

Overview
Journal Korean J Radiol
Specialty Radiology
Date 2022 Feb 25
PMID 35213095
Authors
Affiliations
Soon will be listed here.
Abstract

Transabdominal ultrasound (TAUS) is useful in all aspects of lesion screening, monitoring activity, or treating/diagnosing any related complications of inflammatory bowel disease. Its ability to screen or diagnose complications is almost the same as that of other methods, such as CT or MRI. Moreover, its noninvasiveness makes it a first-line examination method. A TAUS image depicting ulcerative colitis will show large intestinal wall thickening that is continuous from the rectum, which is mainly due to mucosal layer thickening, while for Crohn's disease, a TAUS image is characterized by a diversity in the areas affected, distribution, and layer structure. Indicators of activity monitoring include wall thickness, wall structure, and vascular tests that use Doppler ultrasound or contrast agents. While all of these have been reported to be useful, at this time, no single parameter has been established as superior to others; therefore, a comprehensive evaluation of these parameters is justified. In addition, evaluating the elasticity of lesions using elastography is particularly useful for distinguishing between fibrous and inflammatory stenoses. However, the lack of objectivity is the biggest drawback of using ultrasound. Standardizing and popularizing the ultrasound process will be necessary, including scanning methods, equipment settings, and image analysis.

Citing Articles

The Current Role of Imaging in the Diagnosis of Inflammatory Bowel Disease and Detection of Its Complications: A Systematic Review.

Younis M, Khan M, Khan U, Latif Khan T, Mukarram H, Jain K Cureus. 2024; 16(11):e73134.

PMID: 39507607 PMC: 11540425. DOI: 10.7759/cureus.73134.


Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events.

Kim M, Hwang S Clin Endosc. 2024; 57(6):725-734.

PMID: 39206499 PMC: 11637655. DOI: 10.5946/ce.2024.003.


Ultrasound is not dead, it's immortal!.

Hata J J Med Ultrason (2001). 2022; 49(3):317-318.

PMID: 35951175 PMC: 9365679. DOI: 10.1007/s10396-022-01222-6.

References
1.
Sasaki T, Kunisaki R, Kinoshita H, Yamamoto H, Kimura H, Hanzawa A . Use of color Doppler ultrasonography for evaluating vascularity of small intestinal lesions in Crohn's disease: correlation with endoscopic and surgical macroscopic findings. Scand J Gastroenterol. 2013; 49(3):295-301. DOI: 10.3109/00365521.2013.871744. View

2.
Zoli M, Merkel C, Sabba C, Sacerdoti D, Gaiani S, Ferraioli G . Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. J Ultrasound Med. 1996; 15(2):99-106. DOI: 10.7863/jum.1996.15.2.99. View

3.
Maconi G, Nylund K, Ripolles T, Calabrese E, Dirks K, Dietrich C . EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases. Ultraschall Med. 2018; 39(3):304-317. DOI: 10.1055/s-0043-125329. View

4.
Quaia E, De Paoli L, Stocca T, Cabibbo B, Casagrande F, Cova M . The value of small bowel wall contrast enhancement after sulfur hexafluoride-filled microbubble injection to differentiate inflammatory from fibrotic strictures in patients with Crohn's disease. Ultrasound Med Biol. 2012; 38(8):1324-32. DOI: 10.1016/j.ultrasmedbio.2012.04.008. View

5.
Bolondi L, Gaiani S, Brignola C, Campieri M, Rigamonti A, Zironi G . Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. Scand J Gastroenterol. 1992; 27(6):501-7. DOI: 10.3109/00365529209000112. View